Home > Insider Trading > Filing (0001104659-20-109014)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1429260	Fortress Biotech Inc.	FBIO	Pharmaceutical Preparations (2834)	205157386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1713932	Robyn Hunter	C/O Fortress Biotech, Inc. 2 Gansevoort Street, 9Th Floor New York NY 10014	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Disposition	2020-09-22	28,450	$4.38	192,169	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

In connection with the vesting of 62,500 shares on September 18, 2020, a total of 28,450 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies.
Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on September 22, 2020, was $4.36 to $4.41. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price
Of the 192,169 shares, 62,500 shares are restricted stock units.